Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-17

Clinical Trial Update: Flow-flow ECCO2-R and 4 ml/kg Tidal Volume vs. 6 ml/kg Tidal Volume to Enhance Protection From VILI in Acute Lung Injury [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ECCO2-R-assisted ultra-low tidal volume ventilation (4 ml/kg) with conventional 6 ml/kg tidal volume to reduce ventilator-induced lung i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Turin, Italy | Conditions: Acute Respiratory Distress Syndrome | Phase 3 | Status: TERMINATED